We work closely with each patient to manage and mitigate any side effects, adjusting their regimen as necessary to provide the safest and most effective care possible
Faster return to running through effective treatment carries significant practical value for serious runners
Conflict of interest DK has received research support from Sanofi, Tanabe Pharma, Terumo, Behringer Ingelheim, Kyowa Kirin, Sumitomo Dainippon Pharma, Ono Pharmaceutical and Takeda Pharmaceutical as well as speaker honoraria from Novo Nordisk Pharma, Sanofi, and Takeda Pharmaceutical
Pricing is competitive with the mid-tier providers on this list, and the platform includes regular check-ins with your prescribing clinician to adjust dosing based on your response and side effect profile
Lets take a look at the differences in dosing between the two
As a general rule, people in their 18-65 are the most common candidates